EFEarnings Feed

T

Company dossier

TRANSKARYOTIC THERAPIES INC

CIK 0000885259SIC 2836Biological Products, (No Diagnostic Substances)

Add to watchlist

Exchange

—

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

SEC profile ↗

Recent filings

Latest submissions

7 items

10-QAccepted Nov 14, 7:00 PM ETAcc 0000912057-99-005909
TRANSKARYOTIC THERAPIES INC81.3 KB
TRANSKARYOTIC THERAPIES INC 10-Q
View filing
8-KAccepted Nov 7, 7:00 PM ETAcc 0000912057-99-003757
TRANSKARYOTIC THERAPIES INC85.6 KB
TRANSKARYOTIC THERAPIES INC 8-K
View filing
10-QAccepted Jul 29, 8:00 PM ETAcc 0001047469-99-029226
TRANSKARYOTIC THERAPIES INC224.6 KB
TRANSKARYOTIC THERAPIES INC 10-Q
View filing
10-QAccepted May 10, 8:00 PM ETAcc 0001047469-99-019263
TRANSKARYOTIC THERAPIES INC73.8 KB
TRANSKARYOTIC THERAPIES INC 10-Q
View filing
10-KAccepted Mar 30, 7:00 PM ETAcc 0001047469-99-012664
TRANSKARYOTIC THERAPIES INC293.7 KB
TRANSKARYOTIC THERAPIES INC 10-K
View filing
10-QAccepted Nov 11, 7:00 PM ETAcc 0001047469-98-040353
TRANSKARYOTIC THERAPIES INC80.5 KB
TRANSKARYOTIC THERAPIES INC 10-Q
View filing
10-QAccepted Aug 12, 8:00 PM ETAcc 0001047469-98-031077
TRANSKARYOTIC THERAPIES INC87.5 KB
TRANSKARYOTIC THERAPIES INC 10-Q
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 0

Ticker roster

No tickers on record.

Addresses

business
195 ALBANY ST
CAMBRIDGE, MA, 02139
mailing